CVS earnings show a turnaround in action as the stock rebounds

CVS stock has risen 40% over the last 12 months, vastly outperforming the major indexes and posting returns that rival Nvidia’s, at least in percentage terms. It’s not what you’d expect from a chain of pharmacies where you’re liable to get sticker shock from the price of shampoo and M&Ms. So, what’s the story? For much of the past few years, CVS was treated as a problem stock. In fact, the upward bounce in the stock, year over year, is best explained by the price lows of 2024 and early 2025. Investors we ...